京万红品牌怎么样 申请店铺

我要投票 京万红在医疗器械行业中的票数:411 更新时间:2025-07-07
京万红是哪个国家的品牌?「京万红」是 天津中新药业集团股份有限公司 旗下著名品牌。该品牌发源于天津市,由创始人李立群在1981-12-29期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力京万红品牌出海!将品牌入驻外推网,定制京万红品牌推广信息,可以显著提高京万红产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

京万红怎么样

拥有京万红和痹祺品牌,其中京万红软膏/痹祺胶囊/京万红痔疮膏/橡皮生肌膏/顽癣敌软膏等产品深受广大患者信赖


天津达仁堂京万红药业有限公司与北京同仁堂“乐家老铺”同祖同宗,一脉相承,同为乐家老铺的承袭者。

京万红药业继承乐家老铺秘制的方药,其产品行销东南亚、港澳、欧美等国家和地区。企业拥有软膏剂、胶囊剂、酒剂等七个中药剂型,15个自主知识产权品种;拥有两个非物质文化遗产——《京万红软膏组方与制作技艺》和《乐家老铺沽上药酒传统制作技艺》。

2007年12月28日,企业更名为天津达仁堂京万红药业有限公司,实现了企业名称、商标、产品名称相统一,聚焦在“京万红”品牌上集中发力,迈出了品牌建设的关键一步。企业更名后,赋予了“京万红”品牌新的时代寓意。“京”——代表北京,寓意中国。 “万”——代表亘久绵长,传承永远。“红”——象征顺利、成功、受欢迎。“京万红”寓意着中国的京万红品牌亘久绵长、传承永远、唱响神州,成为享誉全球的国药经典。

企业在承袭内涵深邃的企业文化同时,整合现代科研优势,创建了中药外用药研发转化基地,即天津市中药外用药技术工程中心;为重振企业传统药酒品牌和历史地位,在遵古求新、守正出奇的同时,把传统产业融入创意元素新思维,把药酒的体验式营销与创意产业相结合,创建了融药酒生产与药酒文化展示为一体的乐家老铺沽上药酒工坊。

京万红药业始终恪守乐家老铺祖训“品味虽贵必不敢减物力,炮制虽繁必不敢省人工”和“修合无人见,存心有天知”,并将制药理念和操守进一步延伸为“三不欺”的制药信念——不欺祖,谨遵遗训,以德立业;不欺人,以诚以敬,如事父母;不欺心,襟怀磊落,日月光明;树立了“永远不埋怨、永远找差距、永远有机会”的企业精神;确立了“构建和谐,追求品质”的企业核心文化。企业产品所需中药材原料讲究真实地道,从选材、配料、监测到制作诸环节,都设定了严格的数据管理;制药工艺精益求精,在继承传统制剂工艺的同时,竭力追求技术、设备、管理的现代化。


It has Beijing Wanhong and Biqi brands, among which, Jingwanhong ointment / Biqi Capsule / Jingwanhong Hemorrhoid Ointment / rubber Shengji ointment / stubborn ringworm enemy ointment and other products are deeply trusted by the vast number of patients. Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd. and Beijing Tongrentang "Lejia laopu" share the same ancestor, the same lineage, and the same successor of Lejia laopu. Jingwanhong Pharmaceutical Co., Ltd. inherits the secret prescription made by lejialaopu, and its products are sold in Southeast Asia, Hong Kong, Macao, Europe and America. The company has seven traditional Chinese medicine dosage forms such as ointment, capsule and liquor, 15 varieties with independent intellectual property rights, two intangible cultural heritage - "Beijing Wanhong ointment composition and production technology" and "traditional production technology of liquors in laopugu of Lejia". On December 28, 2007, the company changed its name to Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd., realizing the unification of enterprise name, trademark and product name, focusing on the "Jingwanhong" brand and taking a key step in brand construction. After the company changed its name, it gave the brand "Beijing Wanhong" a new meaning of the times. "Beijing" - on behalf of Beijing, implies China. "Ten thousand" stands for a long time, and is inherited forever. "Red" - a symbol of success, success and popularity. "Jingwanhong" means that the brand of Jingwanhong in China has a long history, has been passed on forever, and has become a world-renowned National Medicine classic. While inheriting the profound corporate culture and integrating the advantages of modern scientific research, the company has established the R & D and transformation base of traditional Chinese medicine for external use, i.e. Tianjin Technology Engineering Center for external use of traditional Chinese medicine. In order to revive the brand and historical position of traditional Chinese medicine liquor, the company has integrated the traditional industry into the new thinking of creative elements, and put the experiential marketing and creative production of traditional Chinese medicine liquor at the same time of abiding by the ancients and being right Combined with the industry, it has established a liqueur workshop integrating the production of liquors and the cultural display of liquors. Beijing Wanhong pharmaceutical industry always abides by the ancestors' motto of laopu of Le family: "although taste is expensive, we dare not reduce material resources, processing is complex, we dare not save manpower" and "no one can see through repair, we have a sense of knowing", and further extends the pharmaceutical concept and ethics to the pharmaceutical belief of "three not deceive" -- not deceive our ancestors, abide by the instructions, build a business based on morality; not deceive others, respect them with sincerity, such as serving our parents; not deceive our hearts, and be open-minded It has established the enterprise spirit of "never complain, always look for the gap and always have the opportunity"; it has established the enterprise core culture of "building harmony and pursuing quality". The raw materials of Chinese medicinal materials required by the products of the enterprise are authentic, and strict data management is set up from material selection, ingredients, monitoring to production. The pharmaceutical process is improved, and the modernization of technology, equipment and management is pursued while inheriting the traditional preparation process.

本文链接: https://brand.waitui.com/667672688.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

知名基金经理调仓动向曝光,密集参与医疗军工板块

2025年行至半程,近期,多家上市公司因回购、重大资产重组等事项披露了最新的前十大流通股东情况,多位知名基金经理上半年的调仓动向浮出水面。梳理公告发现,基金经理在医疗和军工两大板块上的动作较为密集。融通基金万民远在一季度减持东方生物后,二季度再度转为增持,同时对阳光诺和进行了先加后减的操作;葛兰管理的中欧医疗健康混合在二季度新晋迈普医学前十大流通股东,广发基金吴兴武则进行了减持;同时,广发基金的陈韫中、永赢基金的高楠和李文宾对军工股进行了增持。(证券时报)

9分钟前

行情转暖,公募基金定增浮盈最高超两倍

当前,“折价入股”的定增业务逐渐升温,公募基金参与认购的总额近26亿元。随着行情转暖,年内落定的定增项目几乎均有浮盈,浮盈比例最高甚至超过200%。有公募机构认为,当下A股整体估值处于历史中枢水平,若市场面临回调,定增的投资价值或更为凸显。(证券时报)

9分钟前

结构性机会持续涌现,多路资金快步入市

在国内市场结构性机会持续涌现的情况下,多路资金快步入市。私募排排网最新数据显示,7月私募信心指数和加仓意愿指数环比均小幅提升。截至6月末,仓位在五成及以上的私募占比更是超过90%,环比5月末有所提高。与此同时,今年以来已有10余家险企设立或增资私募证券投资基金,入市总规模预计超过2000亿元。除了机构资金,今年上半年个人投资者的风险偏好也显著提升。据统计,上半年私募新备案产品数量环比去年下半年增长超100%。在业内人士看来,伴随着基金赚钱效应显现,政策发力下经济有望逐步回暖,下半年港股和A股结构性行情或进一步演绎。(上证报)

9分钟前

中信建投:市场中枢继续抬高,若调整将迎布局良机

36氪获悉,中信建投研报称,上证指数创2025年以来新高,主要系三维度利好共振:海内外宏观环境持续改善、市场情绪持续高涨、中报业绩预告进一步验证新经济领域增长动能。中期看预计市场震荡中枢将不断抬升,短期指数回调风险加大,若调整则是低位布局良机。行业配置策略上,建议以红利板块筑牢安全边际,高增长领域把握赛道成长潜力,主题投资捕捉结构性机会。重点关注行业包括:电子、通信、医药、煤炭、钢铁、交通运输、新消费、游戏、非银等。

9分钟前

智能眼镜赛道持续升温,北交所公司加速卡位新蓝海

7月4日,北交所上市公司雷神科技公告,为满足用户对智能眼镜服务需求以及拓展智能眼镜销售渠道,公司拟与江苏汇鼎光学眼镜有限公司、欧普康视投资有限公司共同投资设立江苏雷欧汇鼎智能眼镜有限公司,注册资本为人民币1000万元,雷神科技持有35%股权,投资金额为350万元。雷神科技的布局背后正是智能眼镜赛道的火热势头。随着小米、三星等众多消费电子企业入局,智能眼镜赛道渐有“百镜大战”之势,2025年也被认为是智能眼镜爆发元年。(中证报)

9分钟前

本页详细列出关于京万红的品牌信息,含品牌所属公司介绍,京万红所处行业的品牌地位及优势。
咨询